A-PRP: the patient’s platelet concentrate prepared with CellularMatrix, provides an autologous resevoir of growth factors from the patient’s blood.
A revolutionary innovation combining two treatment concepts in one.
Platelets are key factors in hard and soft tissue repair mechanisms 1. They provide essential growth factors, such as FGF, PDGF, TGF-ß, EGF, VEGF, IGF, which are involved in stem cell migration, differentiation and proliferation. Additionally, platelets also stimulate fibroblasts and endothelial cells to induce new extracellular matrix deposition and neo-vascularisation respectively.
Plasma contains many factors essential for cell survival including nutrients, vitamins, hormones, electrolytes, growth factors (such as IGF and HGF), and proteins. Among the plasma proteins, the molecules vital for the coagulation process and for the fibrin polymer formation will serve as a scaffold for cell migration and new tissue generation.
Hyaluronic Acid is the key molecule that has unique capacity in retaining water 2,3,4
Immediate formation, in one easy step, of a cell-friendly HA network in whichplatelets are dispersed, using a system which is specifically approved for preparation of the HA / A-PRP association.
CellularMatrix is a Medical Device that contains 2 ml of natural, non-crosslinked, HA at a concentration of 20 mg / ml (40 mg total) in addition to the thixotropic cell-separation gel and the sodium citrate anticoagulant solution.
Cellular Matrix BCT-HA - Medical Device Class III - CE2797
Intended Use :
Device used to prepare intra-articular injections for symptomatic treatment of articular pain and mobility improvement.